JNJ

JNJ Stock Sinks Following $344 Million Marketing Lawsuit

Drug Manufacturers

JNJ Stock Sinks Following $344 Million Marketing Lawsuit

January 31, 2020

JNJ Stock Gains Slightly on $2 Million USD Talc Case Settlement

Drug Manufacturers

JNJ Stock Gains Slightly on $2 Million USD Talc Case Settlement

January 7, 2020

JNJ Stock Slides As Company Loses Landmark Opioid Case

Drug Manufacturers

JNJ Stock Slides As Company Loses Landmark Opioid Case

August 28, 2019

California Judge Throws Out $417M Cancer Verdict Against Johnson & Johnson

California Judge Throws Out $417M Cancer Verdict Against Johnson & Johnson

October 21, 2017

A Breakdown of Johnson & Johnson’s Major Sector Revenues Since 2Q17

A Breakdown of Johnson & Johnson’s Major Sector Revenues Since 2Q17

September 27, 2017

Johnson & Johnson to Pay $417 Million in Damages After Lawsuit Claims the Company Did Not Properly Address Cancer Risks of its Products

Johnson & Johnson to Pay $417 Million in Damages After Lawsuit Claims the Company Did Not Properly Address Cancer Risks of its Products

August 22, 2017

Arena Pharmaceuticals Shares Gained 45% Today

Arena Pharmaceuticals Shares Gained 45% Today

July 11, 2017

Johnson & Johnson Finally Receives Data from SGLT-2 Inhibitor, Invokana

Johnson & Johnson Finally Receives Data from SGLT-2 Inhibitor, Invokana

June 15, 2017

Three Reasons Why Some Investors Think Johnson & Johnson is a Bearish Stock

Three Reasons Why Some Investors Think Johnson & Johnson is a Bearish Stock

June 14, 2017